Anti-acne drugs in phase 1 and 2 clinical trials-Reference-Cited by-同舟云学术

Anti-acne drugs in phase 1 and 2 clinical trials

Published:2017-06-19 Issue:7 Volume:26 Page:813-823
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Zouboulis Christos C.¹,Dessinioti Clio²,Tsatsou Fragkiski¹,Gollnick Harald P. M.³

Affiliation:

1. Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Theodore Fontane Medical University of Brandenburg, Dessau, Germany

2. Department of Dermatology, Andreas Sygros Hospital, National and Kapodistrian University of Athens, Athens, Greece

3. Department of Venerology and Dermatology, Otto von Guericke University Magdeburg, Magdeburg, Germany

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1337745

Reference86 articles.

1. Can We Define Acne as a Chronic Disease?

2. Acne as a chronic systemic disease

3. Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions

4. Acne vulgaris

5. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in peptide-based antimicrobials: A possible option for emerging drug-resistant infections;Advances in Colloid and Interface Science;2024-11

2. Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation;Frontiers in Drug Discovery;2024-09-06

3. The impact of current investigational drugs for acne on future treatment strategies;Expert Opinion on Investigational Drugs;2024-02

4. Mikrokomedonen und differenzierte Therapie bei Akne;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-01

5. Acne;European Handbook of Dermatological Treatments;2023